A case of paraneoplastic limbic encephalitis associated with small cell lung cancer
- Authors
- Ryu J.Y.; Lee S.H.; Lee E.J.; Min K.H.; Hur G.Y.; Lee S.Y.; Kim J.H.; Lee S.Y.; Shin C.; Shim J.J.; In K.H.; Kang K.H.; Yoo S.H.
- Issue Date
- Nov-2012
- Keywords
- Limbic encephalitis; Lung neoplasms; Paraneoplastic syndromes
- Citation
- Tuberculosis and Respiratory Diseases, v.73, no.5, pp 273 - 277
- Pages
- 5
- Indexed
- SCOPUS
KCI
- Journal Title
- Tuberculosis and Respiratory Diseases
- Volume
- 73
- Number
- 5
- Start Page
- 273
- End Page
- 277
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/12717
- DOI
- 10.4046/trd.2012.73.5.273
- ISSN
- 1738-3536
2005-6184
- Abstract
- Paraneoplastic limbic encephalitis (PLE) is a rare syndrome characterized by memory impairment, affective and behavioral disturbances and seizures. Among many different neoplasms known to cause PLE, small cell lung cancer (SCLC) is the most frequently reported. The pathogenesis is not fully understood but is believed to be autoimmune-related. We experienced a patient with typical clinical features of PLE. A 67-year-old man presented with seizure and disorientation. Brain magnetic resonance imaging demonstrated high signal intensity in the bilateral amygdala and hippocampus in flair and T2-weighted images suggestive of limbic encephalitis. Cerebrospinal fluid tapping revealed no evidence of malignant cells or infection. Positron emission tomography/computed tomography showed a lung mass with pleural effusion and a consequent biopsy confirmed the diagnosis of PLE associated with SCLC. The patient was subsequently treated with chemotherapy and neurologic symptoms gradually improved. Copyright©2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Pulmonary, Allergy, and Critical Care Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.